Membrane Disrupting Lytic Peptides for Cancer Treatments
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2299-2310
Author(s):
Carola Leuschner and William Hansel
Small Molecule Toxins Targeting Tumor Receptors
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2311-2334
Author(s):
Marcin Dyba, Nadya I. Tarasova and Christopher J. Michejda
Cancer-Specific Ligands Identified from Screening of Peptide-Display Libraries
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2335-2343
Author(s):
T. Mori
The Urokinase Receptor as a Potential Target in Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2359-2376
Author(s):
John Romer, Boye Schnack Nielsen and Michael Ploug
An Expanding Appreciation of the Role Chemokine Receptors Play in Cancer Progression
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2377-2389
Author(s):
O.M. Zack Howard and Carole L. Galligan
Drug Delivery Systems Using Immobilized Intact Liposomes: A Comparative and Critical Review
Journal:
Current Drug Delivery
Volume:
1
Page:
299-312
Author(s):
Heidi Brochu, Ange Polidori, Bernard Pucci and Patrick Vermette
Cell-Replacement Therapy with Stem Cells in Neurodegenerative Diseases
Journal:
Current Neurovascular Research
Volume:
1
Page:
283-289
Author(s):
Vincenzo Silani and Massimo Corbo
Peptide Based Vaccine Design for Cancer Immunotherapy
Journal:
Letters in Drug Design & Discovery
Volume:
1
Page:
203-210
Author(s):
D. S. Pouniotis, J. Halton and V. Apostolopoulos
A Stereospecific Route for the Preparation of Trans-Combretastatin Analogs: Synthesis and Cytotoxicity
Journal:
Letters in Drug Design & Discovery
Volume:
1
Page:
275-278
Author(s):
Hari Pati, Zarmeen Taherbhai, Lori Forrest, Martha Wicks, Suzanna Bailey, Andrew Staples, Michelle Stewart, William Pennington, Jeffrey Harris and Moses Lee
Endothelial Endocytic Pathways: Gates for Vascular Drug Delivery
Journal:
Current Vascular Pharmacology
Volume:
2
Page:
281-299
Author(s):
Silvia Muro, Michael Koval and Vladimir Muzykantov